These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21558094)

  • 21. [Association of tuberculosis and HIV infection in Brazil].
    Kritski A; Dalcolmo M; del Bianco R; del Melo FF; Pinto WP; Schechther M; Castelo A
    Bol Oficina Sanit Panam; 1995 Jun; 118(6):542-54. PubMed ID: 7626227
    [No Abstract]   [Full Text] [Related]  

  • 22. Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States.
    LoBue PA; Enarson DA; Thoen TC
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1226-32. PubMed ID: 20843412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Managing tuberculosis in people who use and inject illicit drugs.
    Getahun H; Baddeley A; Raviglione M
    Bull World Health Organ; 2013 Feb; 91(2):154-6. PubMed ID: 23554532
    [No Abstract]   [Full Text] [Related]  

  • 24. [Who must have tuberculosis screening? Characteristics of risk patients].
    MMW Fortschr Med; 2013 May; 155(9):16-8. PubMed ID: 23951641
    [No Abstract]   [Full Text] [Related]  

  • 25. [Screening for tuberculosis].
    Van Vooren JP; Schepers K
    Rev Med Brux; 2013 Sep; 34(4):301-5. PubMed ID: 24195244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weighing gold or counting spots: which is more sensitive to diagnose latent tuberculosis infection?
    Barnes PF
    Am J Respir Crit Care Med; 2006 Oct; 174(7):731-2. PubMed ID: 16988162
    [No Abstract]   [Full Text] [Related]  

  • 27. Tuberculin skin test and predictive host factors for false-negative results in patients with pulmonary and extrapulmonary tuberculosis.
    Almeida Santos J; Duarte R; Nunes C
    Clin Respir J; 2020 Jun; 14(6):541-548. PubMed ID: 32052551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Primary infection and pulmonary tuberculosis].
    Toujani S; Ben Salah N; Cherif J; Mjid M; Ouahchy Y; Zakhama H; Daghfous J; Beji M; Mehiri-Ben Rhouma N; Louzir B
    Rev Pneumol Clin; 2015; 71(2-3):73-82. PubMed ID: 25749628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Strengthening of laboratories is a new component in the global strategy for tuberculosis control].
    Thomsen VØ; Bang D; Kamper-Jørgensen Z; Prahl J; Rasmussen EM; Folkvardsen DB; Frimodt-Møller N
    Ugeskr Laeger; 2011 Mar; 173(12):889-92. PubMed ID: 21419059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New test for the diagnosis of tuberculosis].
    L'Hadj M; Fissah A; Nafti S
    Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S85-10S87. PubMed ID: 17127975
    [No Abstract]   [Full Text] [Related]  

  • 31. Role for interferon-gamma release assays in latent tuberculosis screening before TNF-α antagonist therapy.
    Lioté H; Lioté F
    Joint Bone Spine; 2011 Jul; 78(4):352-7. PubMed ID: 21251863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon-γ release assays versus tuberculin skin test for targeting people for tuberculosis preventive treatment: an evidence-based review.
    Muñoz L; Santin M
    J Infect; 2013 Apr; 66(4):381-7. PubMed ID: 23298892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Tuberculosis, "a sustainable challenge"].
    Ben Kheder A
    Rev Pneumol Clin; 2015; 71(2-3):65-6. PubMed ID: 25113538
    [No Abstract]   [Full Text] [Related]  

  • 34. Potential of interferon-γ-inducible protein 10 in improving tuberculosis diagnosis in HIV-infected patients.
    Aabye MG; Ruhwald M; Praygod G; Jeremiah K; Faurholt-Jepsen M; Faurholt-Jepsen D; Range N; Friis H; Changalucha J; Andersen AB; Ravn P
    Eur Respir J; 2010 Dec; 36(6):1488-90. PubMed ID: 21119209
    [No Abstract]   [Full Text] [Related]  

  • 35. Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection.
    Gupta D; Kumar S; Aggarwal AN; Verma I; Agarwal R
    Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):95-101. PubMed ID: 22117500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of T-cell interferon-gamma release assays for Mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis.
    Kobashi Y; Shimizu H; Ohue Y; Mouri K; Obase Y; Miyashita N; Oka M
    Lung; 2010 Aug; 188(4):283-7. PubMed ID: 20422203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2018 Belgian guidelines for the screening for latent tuberculosis in HIV-infected patients.
    Wyndham-Thomas C; Dirix V; Goffard JC; Henrard S; Wanlin M; Callens S; Mascart F; Van Vooren JP
    Acta Clin Belg; 2019 Aug; 74(4):242-251. PubMed ID: 30036162
    [No Abstract]   [Full Text] [Related]  

  • 39. Latent tuberculosis infection among close contacts of multidrug-resistant tuberculosis patients in central Taiwan.
    Huang YW; Shen GH; Lee JJ; Yang WT
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1430-5. PubMed ID: 20937183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Programmatic utility of tuberculosis cluster investigation using a social network approach in Birmingham, United Kingdom.
    Munang ML; Browne C; Evans JT; Smith EG; Hawkey PM; Welch SB; Kaur H; Dedicoat MJ
    Int J Tuberc Lung Dis; 2016 Oct; 20(10):1300-1305. PubMed ID: 27725038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.